Theriva Biologics, Inc. Annual Return On Equity in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Theriva Biologics, Inc. annual/quarterly Return On Equity history and growth rate from 2014 to 2023.
  • Theriva Biologics, Inc. Return On Equity for the quarter ending December 31, 2022 was -33 %, a 65.8% decline year-over-year.
  • Theriva Biologics, Inc. annual Return On Equity for 2023 was -42.9 %, a 30% decline from 2022.
  • Theriva Biologics, Inc. annual Return On Equity for 2022 was -33 %, a 65.8% decline from 2021.
  • Theriva Biologics, Inc. annual Return On Equity for 2021 was -19.9 %, a 113% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -42.9 -9.91 -30% Jan 1, 2023 Dec 31, 2023
2022 -33 -13.1 -65.8% Jan 1, 2022 Dec 31, 2022
2021 -19.9 -168 -113% Jan 1, 2021 Dec 31, 2021
2020 148 +472 Jan 1, 2020 Dec 31, 2020
2019 -325 -1.38K -131% Jan 1, 2019 Dec 31, 2019
2018 1.06K +101 +10.6% Jan 1, 2018 Dec 31, 2018
2017 956 +5.93K Jan 1, 2017 Dec 31, 2017
2016 -4.97K -4.27K -606% Jan 1, 2016 Dec 31, 2016
2015 -704 -465 -195% Jan 1, 2015 Dec 31, 2015
2014 -239 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.